Bellicum Pharmaceuticals

Crux Biomedical

Crux Biomedical is a private funded company focused on developing improved treatments for the prevention of pulmonary embolisms. Acquired by Volcano Corporation in 2012.

Select Venture Capital & Financial Partners

Alloy Ventures Emergent Medical Partners Three Arch Partners